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Decreased gait speed and health outcomes in older 
adults: Rede FIBRA’s data
Declínio da velocidade da marcha e desfechos de saúde em idosos: dados da Rede Fibra
Disminución de la velocidad de la marcha y resultados en la salud de los ancianos: datos de la 
Red Fibra
Rita de Cássia Guedes1, Rosângela Corrêa Dias2, Anita Liberalesso Neri3, Eduardo Ferriolli4,  
Roberto Alves Lourenço5, Lygia Paccini Lustosa6
ABSTRACT | Gait speed (GS) can predict adverse health 
outcomes. However, an understanding of its associated factors 
is still limited and with some controversy. The objective of this 
study was to identify adverse health outcomes related to the 
decline in gait speed in community-dwelling older adults. This 
is a cross-sectional study that evaluated records of chronic 
diseases and hospitalization in the last year, polypharmacy, 
and gait speed. Logistic regression analysis was used to 
estimate the effects of each independent variable on the 
chance of older adults presenting a decline in gait speed 
(GS<0.8 m/s) (α=5%). In total, 5,501 older adults participated. 
Brazilian older adults with heart diseases (OR=2.06; 1.67-2.54 
CI), respiratory diseases (OR=3.25; 2.02-5.29 CI), rheumatic 
(OR=2.16; 1.79-2.52 CI) and/ or depression diseases (OR=2.51; 
2.10-3.14 CI); hospitalized in the last year (OR=1.51; 1.21-1.85 
CI) and under polypharmacy (OR=2.14; 1.80-2.54 CI) were 
associated with lower gait speed. Thus, the results showed 
that those with gait speed lower than 0.8 m/s are at higher 
risk of some adverse health events. Therefore, it is suggested 
that gait speed should not be neglected in the evaluation in 
community-dwelling older adults, including basic health care.
Keywords | Aged; Gait; Chronic Diseases.
RESUMO | A velocidade da marcha (VM) tem sido 
considerada um marcador de saúde em idosos capaz de 
predizer desfechos adversos de saúde, mas a compreensão 
de fatores associados a ela ainda é limitada e controversa. 
O objetivo deste trabalho é identificar desfechos adversos 
de saúde relacionados ao declínio da velocidade de 
marcha em idosos comunitários. Trata-se de estudo 
transversal e multicêntrico, que avaliou o autorrelato 
de doenças crônicas e de hospitalização no último ano, 
polifarmácia e velocidade de marcha. Utilizou-se análise de 
regressão logística para estimar os efeitos de cada variável 
independente na chance de os idosos apresentarem 
declínio na velocidade de marcha inferior (VM<0,8m/s) 
(α=0,05). Participaram da pesquisa 5.501 idosos. A menor 
velocidade da marcha mostrou-se associada a portadores 
de doenças cardíacas (OR=2,06; IC: 1,67-2,54), respiratórias 
(OR=3,25; IC: 2,02-5,29), reumáticas (OR=2,16; IC: 1,79-2,52) 
e/ou depressão (OR=2,51; IC: 2,10-3,14), hospitalizados 
no último ano (OR=1,51; IC: 1,21-1,85) e polifarmácia 
(OR=2,14; IC: 1,80-2,54). Assim, os resultados indicaram 
que idosos com velocidade de marcha menor que 0,8m/s 
apresentam maior risco de eventos adversos de saúde. 
Dessa forma, sugere-se que a velocidade de marcha não 
seja negligenciada na avaliação de idosos comunitários, 
inclusive na atenção básica.
Descritores | Idoso; Marcha; Doenças Crônicas.
RESUMEN | La velocidad de la marcha (VM) se ha 
considerado un marcador de salud en los ancianos capaz 
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de predecir resultados adversos en la salud, pero la comprensión 
de sus factores asociados todavía es limitada y controvertida. El 
presente estudio tiene como objetivo identificar los resultados 
adversos para la salud relacionados con la disminución de la 
velocidad de la marcha en los ancianos comunitarios. Se trata 
de un estudio transversal y multicéntrico, el que evaluó el 
autoinforme de enfermedades crónicas y de la hospitalización 
en el último año, la polifarmacia y la velocidad de la marcha. 
Se utilizó el análisis de regresión logística para estimar los 
efectos de cada variable independiente sobre la posibilidad 
de que los ancianos presenten una disminución más baja en la 
velocidad de la marcha (VM<0,8 m/s) (α=0,05). Participaron 
en el estudio 5.501 ancianos. La velocidad de marcha más baja 
estuvo asociada a portadores de enfermedades cardíacas 
(OR=2,06; IC: 1,67-2,54), respiratorias (OR=3,25; IC: 2,02-5,29), 
reumáticas (OR=2,16; IC: 1,79-2,52) y/o depresión (OR=2,51; IC: 
2,10-3,14), hospitalizados en el último año (OR=1,51; IC: 1,21-
1,85) y polifarmacia (OR=2,14; IC: 1,80-2,54). De esta manera, 
los resultados indicaron que los ancianos con velocidades de 
marcha por debajo de 0,8m/s presentan un mayor riesgo de 
eventos adversos para la salud. Por lo tanto, se sugiere que la 
velocidad de la marcha no debe ser descuidada en la evaluación 
de ancianos comunitarios, incluso en la atención primaria.
Palabras clave | Anciano; Marcha; Enfermedades Crónicas. 
INTRODUCTION
Physical function decreases with age and predicts 
higher rates of disability, institutionalization and death. 
Thus, maintaining the functional capacity of older adults is 
crucial to extend an independent life1,2. The accumulation 
of diseases negatively influences functional capacity and 
quality of life3,4. In the context of functional capacity, gait 
consists of a dynamic activity that is fundamental for 
the accomplishment of the activities of daily living and 
necessary for the independence of individuals5. However, 
gait tends to become slower with aging, suggesting 
that everyone selects the speed most compatible with 
their functional abilities. Thus, gait slowness arises due 
to the physiological process of aging, often associated 
with already established clinical conditions or those 
that have not yet manifested, remaining silent in the 
clinical setting of older adults6.
Given this context, usual gait speed has been 
considered a predictor of functional decline, 
hospitalization, hospital discharge, caregiver need 
and mortality7. Likewise, it has been associated with 
a higher incidence of fractures, institutionalization and 
changes in quality of life, factors that increase health 
costs8,9. Studies have observed that a 0.1 m/s reduction 
in gait speed increases the risk of death by 12%7,10, 
and that older individuals with decreased gait speed 
are 2.5 times more likely to present adverse health 
outcomes11. Thus, gait speed has been considered as a 
“sixth vital sign” and a functional health marker6 due to 
its importance as an indicator of health and function, 
as well as its easy evaluation and interpretation.
The International Academy on Nutrition and Aging 
(IANA) identified several cut-off points for gait speed, 
ranging from 0.15 m/s to 1.3 m/s, related to adverse 
health outcomes such as falls, heart and lung disease, 
frailty, sarcopenia, hospitalization, institutionalization 
and death8. Studenski et al.7 used the 0.8 m/s cut-
off point and demonstrated that older people with 
faster gait speed had longer life expectancy. Moreover, 
the presence of chronic diseases, polypharmacy, low 
social and educational conditions have also been 
related to declining gait speed, mobility and worse 
health prognosis3,5,8,11. However, there is still limited 
understanding of its associated factors and their 
implications in various populations. A recent study 
demonstrated the influence of economic and social 
factors and life expectancy at birth with gait speed 
changes, considering the domains of the Human 
Development Index (HDI)12.
This study sought to determine the risk of adverse 
health outcomes (heart, respiratory and rheumatic 
diseases, systemic arterial hypertension, diabetes mellitus, 
cancer, osteoporosis, depression, hospitalization and 
polypharmacy) to declining gait speed of community-
dwelling older adults .
METHODOLOGY
This is a cross-sectional, multicenter study that is 
part of the Frailty in Brazilian Older People Network 
(Rede Fibra) project. This multidisciplinary network 
evaluated older adults living in different cities of the 
five Brazilian regions, selected using a randomization 
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process in census-designated places. The sample selection 
and the inclusion/exclusion criteria have already been 
published in previous studies13,14. Thus, community-
dwelling individuals, older than 65 years, who agreed 
to participate in the interview and physical tests and 
signed the Informed Consent Form were invited 
to participate in the study13. Data were collected at 
participants’ homes by trained researchers in previously 
scheduled interviews. This study followed the guidelines 
for strengthening the reporting of observational studies 
in epidemiology (Strobe).
Exclusion criteria were: having severe sequelae caused 
by stroke and/or neurological diseases that prevented 
the tests; use of a wheelchair or being bedridden; and 
presenting cognitive deficit indicated by a score of less 
than 17 in the mini-mental state exam15. To meet the 
objectives of this study, Rede Fibra’s national bank 
was analized, containing information collected in all 
participating cities.
The dependent variable was the usual gait speed 
(m/s), evaluated at 4.6m, plus 2m for acceleration and 2m 
for deceleration. Participants wore their usual footwear. 
Participants were instructed to walk at their normal 
speed. Travel time was timed from the voice command 
“Ready? Go…”. Three measurements were taken, and 
the mean was used for the analyses. Gait speed was 
used as categorical variable, using the 0.8m/s cut-off 
point, indicated as the most sensitive value to identify 
the influence of adverse health outcomes7,8,16-18. The 
sample was then categorized into a group composed of 
participants with gait speed below 0.8m/s and another 
group formed by participants with gait speed equal to 
or greater than 0.8 m/s.
The independent variables were evaluated with a 
multidimensional survey standardized by Rede Fibra, 
with interviews and self-reported information. This 
methodology was used in the studies of Rede Fibra13,14. 
The following variables were selected for this study: 
self-reported presence of chronic diseases diagnosed by 
a physician (heart, respiratory and rheumatic diseases, 
systemic arterial hypertension, diabetes mellitus, cancer, 
osteoporosis and depression) (“Have you ever been 
diagnosed with…”); self report of hospitalization in 
the last 12 months (“Have you been hospitalized in the 
last 12 months?”) and polypharmacy (defined as the 
use of four or more regular medicines during the last 
three months, either by consulting medicine packages 
and/or prescription).
Statistical analysis 
The study was based on a probabilistic sample of 
community-dwelling older adults, stratified according 
to the older adult population density, based on data from 
the 2000 census conducted by the Brazilian Institute 
of Geography and Statistics (IBGE). The sample size 
required for a population proportion of 50% of a given 
characteristic under study (value in which the sample 
size obtained was the maximum possible (p=0.50, 
q=0.50) was estimated to determine the sample of 
each city, according to their older adult population. The 
significance level was set at 5% (α=0.05, Z=1.96). The 
sample error ranged from 3% to 5%. Based on these 
estimates, the sample size of cities with more than 
one million inhabitants was set at 601 older adults, 
considering 4% error. For cities with less than one 
million inhabitants, the sample value was set at 385 
older adults, considering 5% error.
The sample description was given by mean and standard 
deviation for continuous variables, and percentage 
for categorical variables. Data distribution analysis 
was performed using the Kolmogorov-Smirnov test. 
Differences between groups were assessed by Kruskall-
Wallisand chi-square tests. Variables with p-values 
greater than 0.10 in bivariate analyses were excluded 
from multivariate analyses. A binary logistic stepwise 
forward regression model was traced with the gait speed 
dependent variable (categorized as less than 0.8m/s 
or greater than 0.8m/s) and as independent variables 
(self-reported presence of heart disease, respiratory 
and rheumatic; systemic arterial hypertension; diabetes 
mellitus; cancer, osteoporosis and depression, diagnosed 
by a doctor; hospitalization and polypharmacy). Thus, 
this analysis sought to explore the association of risk 
of independent variables with the dependent variable 
(gait speed lower than 0.8m/s when compared to older 
individuals with gait speed equal to or greater than 
0.8m/s). The odds of each independent variable to 
be associated with gait speed were analyzed by odds 
ratio (OR) and 95% confidence interval (CI). As they 
were not the objective of this study, sociodemographic 
variables were excluded from the model. All analyses 
were performed in the SPSS 17.0 statistical program 
and the significance level considered was 5%.
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RESULTS
In total, 5501 older adults all over Brazil participated 
in this study (Rede Fibra). Most were women (66.20%) 
and the mean age was 73.01±6.17 years. The overall mean 
gait speed was 1.00±0.69 m/s, and 34.26% of the older 
adults had GS<0.8 m/s. Thus, the older adults classified 
in this group – GS<0.8m/s – presented greater chronic 
diseases rates. Univariate analyses showed statistically 
significant differences among the older adults with 
GS<0.8 m/s and GS≥0.8 m/s when compared to all 
independent variables (p<0.05), except for those with 
cancer reports. Table 1 shows these results and other 
sample characteristics.
Variables with p-value greater than 0.10 were excluded 
from the model of the multivariate analyses. Thus, the 
model that best explained gait speed identified that older 
adults reported receiving medical diagnosis of heart 
disease, respiratory diseases, rheumatic diseases and/or 
depression. They also reported having been hospitalized 
in the last 12 months and using four or more medicines 
regularly in the last three months. They showed a greater 
chance of having GS<0.8m/s. In this case, with these 
conditions, Table 2 showed at least a 1.51 greater chance 
of older adults presenting gait speed decline. Self-report 
of systemic arterial hypertension, diabetes mellitus, cancer 
and osteoporosis, even if initially different, did not remain 
in the final model.
Table 1. Mean, standard deviation and frequency of distribution of independent variables, comparing older adults with GS<0.8 m/s and 
those with GS≥0.8 m/s and p-value 
Characteristics Total sample (N=5501) Older adults GS<0.8 m/s (N=1885) 
Older adults GS≥0.8 m / s 
(N=3616) p-value
Age (Yrs), Mean ± SD 73.01±6.17 75.11±6.77 72.18±5.65 <0.01*
Sex <0.01*
Men, n (%) 1862 (33.81) 476 (25.30) 1386 (38.30)
Women, n (%) 3639 (66.20) 1409 (74.70) 2230 (61.70)
Heart diseases, n (%) 1005 (18.30) 590 (31.30) 415 (11.50) <0.01*
Respiratory diseases, n (%) 435 (7.90) 385 (20.40) 50 (1.40) <0.01*
Rheumatic diseases, n (%) 1738 (31.60) 852 (45.20) 886 (24.50) <0.01*
Systemic Arterial Hypertension, n (%) 3173 (57.70) 1127 (59.80) 2046 (56.60) 0.02*
Diabetes mellitus, n (%) 1079 (19.60) 665 (18.40) 414 (22.00) <0.01*
Cancer, n (%) 260 (4.70) 79 (4.20) 181 (5.00) 0.09
Osteoporosis, n (%) 1183 (21.50) 457 (24.30) 726 (20.10) <0.01*
Depression, n (%) 908 (16.50) 352 (18.70) 556 (15.40) 0.02*
Hospital admission in the last year, n (%) 893 (16.20) 437 (23.20) 456 (12.60) <0.01*
Polypharmacy, n (%) 1719 (31.24) 852 (45.20) 867 (24.00) <0.01*
SG (m/s), mean ± SD 1.0±0.69 0.59±0.15 1.06±0.19 <0.01*
SD: standard deviation; GS: normal gait speed; * significant difference.
Table 2. Odds ratio, confidence interval and statistical significance 
of the factors associated with GS lower than 0.8 m/s in the older 
adult sample of Rede Fibra
VARIABLES OR 95%CI p-value
Heart diseases 2.06 (1.67 – 2.54) <0.01*
Respiratory diseases 3.25 (2.02 – 5.29) 0.01*
Rheumatic diseases 2.16 (1.79 – 2.52) <0.01*
Depression 2.51 (2.10 – 3.14) <0.01*
Hospitalization 1.51 (1.21 – 1.85) <0.01*
Polypharmacy 2.14 (1.80 – 2.54) <0.01*
GS: normal gait speed; 95%CI: 95% confidence interval; OR: odds ratio; * significant difference.
DISCUSSION
This study sought to analyze the relationship between 
some adverse health outcomes (heart, respiratory and 
rheumatic diseases, systemic arterial hypertension, diabetes 
mellitus, cancer, osteoporosis, depression, hospitalization 
and medication) with the gait speed decline in older 
adults. The results showed that those with GS<0.8m/s 
had a greater history of hospitalization, some clinical 
conditions and greater use of medicines. These results 
confirm the Brazilian and international literature, and 
point to energy reserve reduction and homeostasis loss 
in the aging process1-6.
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Older adults with a diagnosis of heart disease such 
as angina, myocardial infarction or heart failure were 
2.06 times more likely to have GS<0.8 m/s. Chronic 
diseases, in general, cause muscle mass reduction as a 
consequence of pathophysiological processes that increase 
cell catabolism19, which could be one of the reasons for this 
strong association. Similarly, the literature indicates that 
respiratory symptoms, reduced mobility and heart disease 
are present in old age and associated with important health 
outcomes20. Our results also showed those with bronchitis 
and/or emphysema were 3.25 times more likely to have 
GS<0.8m/s. Given this context, previous studies have 
confirmed our result, identifying an association between 
reduced gait speed and increased lung disease severity 
and a strong negative correlation between gait speed 
and dyspnea severity21. These results can be justified by 
the restriction and decrease of aerobic capacity of older 
adults with such conditions.
Rheumatic diseases are also associated with functional 
decline and slow gait in older adults22. In this case, gait 
speed reduction can be interpreted as a consequence of 
muscle weakness in the lower limbs and of proprioceptive 
changes that compromise the postural balance in 
individuals with these diseases. Moreover, the tendency 
for cadence, and step and stride size decrease is evidenced 
as a strategy to reduce compressive forces in lower limb 
joints and, consequently, relieve the pain caused by joint 
and rheumatic diseases22,23. These results corroborate with 
studies on specific gait parameters12,22,23.
 Older adults with greater number of depressive 
symptoms demonstrated a 2.51 times greater chance 
of walking in GS<0.8m/s. This result confirmed the 
literature that points out that depression and gait slowness, 
and other chronic-degenerative conditions previously 
discussed, occur frequently and simultaneously in old 
age. These conditions are associated with disabilities, 
cognitive decline, environmental and psychosocial 
factors that may influence one’s health24-26. Our results 
do not allow to infer about causality; however, they have 
relevance when demonstrating the association between 
these conditions, confirming that GS can be considered 
a functional health marker.
Elderly people with a higher number of chronic 
degenerative conditions tend to use a larger number 
of medicines, which may also impact on overall and 
functional health27. This assumption was also confirmed 
in this study, which pointed out that those who regularly 
used four or more medicines had 2.14 higher chances of 
having GS<0.8 m / s. Peron et al.28 demonstrated that the 
use of drugs such as benzodiazepines, anticholinergics, 
antidepressants and antihypertensives were associated 
with worse functional status. In our study, the specific type 
of drug used by the elderly were not analyzed but only 
the number of medicines in use, which can be considered 
a limitation of this study and should be explored in 
future studies.
Older adults who reported being hospitalized in the 
last 12 months had a 1.51 times greater chance of walking 
at GS<0.8m/s. After discharge, patients often experience 
negative short-, medium- and long-term consequences 
such as functional decline, disability, new hospitalization, 
institutionalization and death26. Recent studies have shown 
functional capacity reduction during hospitalization, 
which cannot be recovered after hospital discharge29, 
reaching 19% of functional capacity with limitations on 
basic activities of daily living and 40% on instrumental 
activities of daily living after hospitalization29,30. In this 
case, the number of hospitalizations and their reasons 
were not analyzed, which may also be a limitation in the 
interpretation of this data. Likewise, reporting the time of 
diagnosis of diseases in future studies is also important, as a 
greater restriction of mobility and functional capacity may 
be associated with disease aggravation and chronification.
The significant difference of age observed between 
the groups is important to be discussed. Although we 
acknowledge the evidence of sociodemographic variables, 
this study did not seek to explore them12. The age presents 
multicolinearity, mainly when compared with heart, 
respiratory, rheumatic and hospitalized diseases, not 
justifying its analysis in the model. Given this context, 
it is known that gait and its spatiotemporal parameters 
tend to change over the years and with some diseases5,6,31. 
Some authors have demonstrated a physiological loss, 
including in gait speed, inherent to the aging process12,31. 
Thus, given the multicollinearity of age with the 
independent variables analyzed, we suggest future studies 
with longitudinal and mediation analyses to verify the 
magnitude of age influence.
 Finally, our data are relevant because this is a 
multicenter study, ensuring the participation of older 
adults in the five regions of Brazil, and the possibility of 
knowing the characteristics of the studied population. As 
the literature points out, gait speed may be influenced by 
contextual, socioeconomic and clinical factors, and access 
to health services12. In the case of Brazil, which presents 
continental dimensions and great regional diversity, this 
study is the first step to better understand the gait behavior 
of community-dwelling older adults, which can subsidize 
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health policies for this population and others with similar 
characteristics. Thus, from the clinical applicability point 
of view, the results found in this study suggest that gait 
speed can be considered a health marker for community-
dwelling older adults. This study thus suggests the use of 
this measure in clinical practice and greater attention to 
those with a slower gait.
CONCLUSION
The results of this study showed that the older adults 
with gait speed slower than 0.8m/s were at higher risk of 
adverse health events (heart, respiratory and rheumatic 
diseases, systemic arterial hypertension, diabetes mellitus, 
cancer, osteoporosis hospitalization and polypharmacy). 
Thus, gait speed should not be neglected in the evaluation 
of older adults, even in basic care.
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